QI
OGN icon

QS Investors’s Organon & Co OGN Stock Holding History

QS Investors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$915K Buy
+30,217
New +$995K 0.01% 519

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

QS Investors's OGN Position: Q2 2021 in Review

QS Investors opened a new position in Organon & Co (OGN) in Q2 2021: 30,217 shares worth $915K. The stake represents 0.01% of the portfolio and ranks #519 among its holdings.

988 funds tracked by Wall St. Rank hold OGN as of Q2 2021.

  • QS Investors held 30,217 shares of Organon & Co worth $915K as of Q2 2021.
  • Organon & Co was a new QS Investors position in Q2 2021.
  • Organon & Co made up 0.01% of QS Investors's portfolio in Q2 2021, its #519 holding.
  • 988 funds tracked by Wall St. Rank held Organon & Co as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.